Parkinson's disease and parkinsonism - Injection with the heroin contaminant MPTP Factor
Last reviewed for CCPS 26 September 2007.
Investigative Documents
Claimant Report - Injection Containing MPTP - Parkinson's Disease and Parkinsonism [CR9162]
Preliminary questions [23253]
there is some evidence that an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) may be a factor in the development or worsening of the condition under consideration.23346 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for Parkinson's disease or parkinsonism.
23347 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical onset of parkinsonism.
23349 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical onset of parkinsonism.
or
23350 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical onset of parkinsonism.
or
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.
the condition under consideration permanently worsened.23348 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical worsening of Parkinson's disease or parkinsonism.
23351 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical worsening of Parkinson's disease or parkinsonism.
or
23352 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical worsening of Parkinson's disease or parkinsonism.
Clinical onset and operational service [23349]
38596 — the veteran has parkinsonism.
on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration. the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable. the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.23355 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.
Clinical onset and eligible service [23350]
38596 — the veteran has parkinsonism.
on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration. the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable. the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.23356 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.
Clinical worsening and operational service [23351]
on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration. the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable. the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.23355 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.Clinical worsening and eligible service [23352]
on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration. the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable. the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.23356 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.